Market Research Logo

Gastrointestinal Market Research Reports & Industry Analysis

Gastrointestinal (GI) or gastroenterology is the branch of medicine related to the GI tract (stomach and intestines) and the accessory organs of digestion (from the mouth to the anus). Some of the conditions treated under this specialty include but are not limited to: Crohn’s disease, gastroesophageal reflux disease (GERD), inflammatory bowel disease, irritable bowel syndrome, peptic ulcer disease, celiac disease, colon cancer, heartburn, gastric cancer, diverticulitis, and ulcerative colitis.

While many of these illnesses are chronic and can only be treated medically, more holistic and natural approaches are being used more frequently to prevent and manage gastrointestinal disorders. Many healthcare providers are recommending stress management, a healthy diet, and exercise to prevent and manage symptoms.

Exercise has shown to decrease the risk of colon cancer, minimize constipation and improve overall GI health. Even minimal exercise paired with a healthy diet of fruits, vegetables, low fat protein and avoidance of red meat, animal fat, and processed meats, can go a long way in preventing colon cancer and other GI diseases.

It is known that psychological stress can aggravate symptoms of Crohn’s disease, irritable bowel syndrome, and ulcerative colitis. Taking a mind-body approach to health can help these patients manage their illnesses. Techniques such as yoga, meditation, massage, and acupuncture can lower stress and in turn reduce bowel symptoms. Doctors also recommend an anti-inflammatory diet (omega-3 fatty acids, fruits & vegetables, and protein rich food like fish, chicken and soy) for people suffering from Crohn’s disease.

...Show More ...Show Less


Filter your search

Research Assistance

Join Alert Me Now!

Sign Up

Find out more on our blog

Gastrointestinal Industry Research & Market Reports

  • Gastrointestinal Cancer Drug Pathway Analyzer

    ...plethora of treatment strategies is based on our increasing understanding of the 174 drug targets that are included in this drug-pathway analyzing tool. No less than 167 of these have been recorded with mutations and ... Read More

  • Target Atlas in Gastrointestinal Cancer: A Competitive Outlook

    ...Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Gastrointestinal Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ... Read More

  • Global Over The Counter (OTC) Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin

    ...the market is further expected to reach a value of USD 220 billion by 2021, growing at an expected CAGR of 10.6% during the forecast period of 2016-2021. Over the counter drugs are medications that ... Read More

  • Global Alimentary Tract and Metabolism Market Research Report 2016

    ...(North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Alimentary Tract and Metabolism basics: definitions, classifications, applications and industry chain overview; industry policies and ... Read More

  • Gastrointestinal Cancer Drug Pipeline Update

    ...of ceased drugs over the last years amount to another 80 drugs. Gastrointestinal Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked ... Read More

  • Gastroesophageal (GE) Junction Carcinomas-Pipeline Insights, 2016

    ...in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent ... Read More

  • Gastrointestinal Tract Cancer-Pipeline Insights, 2016

    ...stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ... Read More

  • Gastroparesis-Pipeline Insights, 2016

    ...Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ... Read More

  • Helicobacter Pylori Infections-Pipeline Insights, 2016

    ...stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ... Read More

  • North America Endoscopic Accessories Market - By Product (Carts, Cleaning Adapters, Lubrication Gel), By Application (Laparoscopy, Gastrointestinal Endoscopy), By Country (U.S. Canada Mexico) FORECASTS TO 2021

    ...segmented based on product, application, and geography. The product segment includes mouthpieces, biopsy valves, suction polyp trap, quick catch polyp trap, distal attachments, spray catheters, bite blocks, lubrication gels, overtubes, cleaning adaptors to name a ... Read More

  • Functional (Non Ulcer) Dyspepsia-Pipeline Insights, 2016

    ...in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent ... Read More

  • Gastritis-Pipeline Insights, 2016

    ...Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ... Read More

  • Peptic Ulcers-Pipeline Insights, 2016

    ...development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ... Read More

  • Traveler's Diarrhea-Pipeline Insights, 2016

    ...development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ... Read More

  • Dyspepsia-Pipeline Insights, 2016

    ...Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ... Read More

  • Gastrointestinal Bleeding-Pipeline Insights, 2016

    ...development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ... Read More

  • Constipation-Pipeline Insights, 2016

    ...Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ... Read More

  • Gastric Ulcers-Pipeline Insights, 2016

    ...development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ... Read More

  • Gastroenteritis-Pipeline Insights, 2016

    ...Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ... Read More

  • Gastrointestinal Stromal Tumor (GIST)-Pipeline Insights, 2016

    ...in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent ... Read More

  • Colitis - Pipeline Review, H2 2016

    ...for Colitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete ... Read More

  • Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H2 2016

    ...pipeline landscape. The report provides comprehensive information on the therapeutics under development for Reflux Esophagitis (Gastroesophageal Reflux Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) ... Read More

  • Constipation - Pipeline Review, H2 2016

    ...for Constipation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete ... Read More

  • Diarrhea - Pipeline Review, H2 2016

    ...for Diarrhea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete ... Read More

  • Helicobacter pylori Infections - Pipeline Review, H2 2016

    ...information on the therapeutics under development for Helicobacter pylori Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the ... Read More

3 4 5 6 8 10 11 12